HemoGuard is an AI-powered digital health initiative from Center of Excellence in AI, Bahria University and SEECS, NUST that empowers individuals with insights into thalassemia minor carrier status using routine Complete Blood Count (CBC) reports — a non-invasive, cost-effective alternative to genetic testing.
Our mission is to support early screening and awareness, reduce new thalassemia major births, and empower family planning decisions with smart technology.
Key Highlights:
• AI + CBC based non-invasive thalassemia carrier detection
• NLP-driven screening recommendations
• Backed by medical experts and national research grants
• Collaborations with labs, universities & public health departments
Join us in the fight against thalassemia.
#HemoGuard #AIForHealth #ThalassemiaAwareness
Company Details
- Founded
- -
- Address
- Islamabad, Pk
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Keywords
- Beyond the Bloodline.
- HQ
- Islamabad
Hemoguard – Ai-Based Thalassemia Screening Questions
Hemoguard – Ai-Based Thalassemia Screening's LinkedIn profile is https://pk.linkedin.com/company/hemoguard
Hemoguard – Ai-Based Thalassemia Screening's industry is
Health and Human Services
Hemoguard – Ai-Based Thalassemia Screening's top competitors are
Samco Industries,
Developershub Corporation©,
Center Of Excellence - Artificial Intelligence,
Antematter,
All Purpose Pumps,
10pearls Pakistan.
Hemoguard – Ai-Based Thalassemia Screening's categories are Health and Human Services
Hemoguard – Ai-Based Thalassemia Screening's founding year is 2022
